Inotuzumab ozogamicin (INO), an antibody-drug conjugate approved for the treatment of relapsed or refractory acute lymphoblastic leukemia (ALL), appears to be safer and more effective than standard care for patients with both higher and lower cluster of differentiation-22 (CD22) expression.
A leukemia expert provides a model for how to respond to patients’ questions about cancer and their COVID-19 risk.
New research indicates that contemporary risk of ACC based on size in adrenal incidentaloma may be less than the current recommendations.
Fairly simple adjustments to treatment plans can make a significant difference for a child or young adult with a dual diagnosis of cancer and autism spectrum disorder. Pediatric hematologist-oncologist Rabi Hanna, MD, explains.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Early data from an ongoing clinical trial show that patients with active or previous malignancy who contract COVID-19 have high 30-day all-cause mortality associated with both general and cancer-related risk factors.
A new study examining the gene phosphate and tensin homolog (PTEN) calls for both early detection of cancer and awareness of the importance of precision therapy.
Studying the role of CSCs in cancers of the brain, colon, rectum, breast, lung, bone marrow and more may one day help develop new treatments. A look at our new Center for Cancer Stem Cell Research, led by Shideng Bao, PhD.
From patient-staff models to placing electrical outlets, nurses were part of the team making decisions for the new cancer center. Learn more about how it worked.
By now most rheumatologists are aware that checkpoint inhibitors are capable of unleashing a wide array of autoimmune and autoinflammatory adverse events within virtually every organ system. These complications have posed new challenges to all practitioners.
Cleveland Clinic began offering shared medical appointments for early stage post-extraction melanoma patients in August hoping to change self-care behaviors and prevent recurrence of the disease.